Mind the (technology) gap
In working with many different organizations to adopt resilient clinical trial strategies, one thing has become clear to me: the directive must come from the C-suite.
In working with many different organizations to adopt resilient clinical trial strategies, one thing has become clear to me: the directive must come from the C-suite.